HAL will be down for maintenance from Friday, June 10 at 4pm through Monday, June 13 at 9am. More information
Skip to Main content Skip to Navigation
Journal articles

Rituximab's cost for the treatment of primary cold agglutinin disease should not limit its use.

Document type :
Journal articles
Complete list of metadata

https://hal.univ-brest.fr/hal-00689153
Contributor : Ghislaine Calvez Connect in order to contact the contributor
Submitted on : Thursday, April 19, 2012 - 1:40:29 PM
Last modification on : Thursday, March 31, 2022 - 11:00:02 AM

Identifiers

  • HAL Id : hal-00689153, version 1
  • PUBMED : 16533732

Collections

Citation

Aurelien Delluc, Elisabeth Pasquier, Luc de Saint Martin, Dominique Mottier. Rituximab's cost for the treatment of primary cold agglutinin disease should not limit its use.. Haematologica, Ferrata Storti Foundation, 2006, 91 (3), pp.ECR05. ⟨hal-00689153⟩

Share

Metrics

Record views

23